© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
March 18, 2022
Best practices call for referring to resources, such as those from HHS and the University of Liverpool.
January 17, 2022
Monoclonal antibodies and emerging agents may avert severe illness, especially for high-risk individuals.
November 16, 2021
Duration of therapy may be just 5 to 6 days for patients without risk factors for complications.
September 17, 2021
PrEP simplifies management of the virus by eliminating the need for immune globulin and decreasing the number of doses needed.
July 23, 2021
Consider key elements of acute bacterial skin and skin structure infection to help patients manage this broad range of diseases.
May 24, 2021
FDA approval of 2-drug injectable Cabenuva is a game changer in maintaining viral suppression in patients.